Newsletter | March 14, 2026
CLINICAL SITES
Why Sponsors Should Share KPI Rationale With Sites
By Amy Bland, Curo Research
Early Phase Clinical Trial Enrollment: Avoid Delays From The Start
AutoCruitment
The Promise Of IQVIA One Home For Sites: A Site CEO's Perspective
By Dan Kearney, CNS Healthcare
PATIENT CENTRICITY
Patient Trust In Pharma Is Low; Here's How To Rebuild It
By Shalome Sine and Annick de Bruin, CISCRP
Expanding Influenza Study Access Via Community-Based Research
EmVenio Clinical Research
How The FDA Is Helping To Operationalize Patient Voice In Trials
By Alysia Drummond, InSeption Group
PATIENT RECRUITMENT
What ChatGPT Ads Will Really Mean For Clinical Trials
By Ross Jackson
Rethinking Alzheimer's Trial Recruitment And Why It Can't Wait
By Joanna Pulawska, Ph.D., IQVIA Biotech
CLINICAL TRIAL TECHNOLOGY
When A Clinical Trial Surfaces In An AI Chat, What Happens Next?
The EMR Interoperability Dream Vs. Clinical Research Reality
Castor
Why Protocol‑Driven eSource Solves Data Capture For 80% Of Sites
CRIO
DECENTRALIZED TRIALS
CISCRP's Mobile Health Exhibit Brings Clinical Trial Education To Communities
By Justine Holleran and Shalome Sine, CISCRP
TRIAL MANAGEMENT
Becoming A Backbone Therapy: Lessons Learned With Actuate Therapeutics
A conversation with Dan Schmitt, Actuate Therapeutics
4 Core Biomarker-Driven Study Designs In Oncology
By Paul Steven, Precision for Medicine
RTSM Reusability: Why Most Systems Lack It And Why It Matters
By Chuck Harris, Korio
Strategies For Efficient Clinical Supply Management And Forecasting
By Kristen DeVito, Catalent Pharma Solutions
The Clinical Trial Rescue Triage Playbook
20/20 Onsite
Whole Health In Action: Real-World Examples Of Better Outcomes
ISPOR—The Professional Society for Health Economics and Outcomes Research
Modernizing Clinical Trial Logistics To Deliver Value
Thermo Fisher Scientific
REGULATORY & COMPLIANCE
FDA's Draft Guidance On Bayesian Methods: Strategic Implications For Small Biotechs
By Jessica Cordes, Clinical Excellence GmbH
Understanding The FDA's Push For More Representation
By Miranda McLaren, EmVenio Clinical Research
Measuring Treatment Tolerability In Oncology: Expert Panel Discussion
Signant Health
Does Your Drug Require A Driving Study? Find Out What The FDA Says.
Altasciences
OUTSOURCING MODELS
Outsourcing? When Both Sides Of The Table Are Investor-Backed, Everything Changes
By Kishore Hotha, Dr. Hotha’s Life Sciences LLC
Serbia: Europe's Emerging Clinical Trial Powerhouse
Palleos
Fast-Tracking FIH To PoC: Strategies For Accelerated Drug Development
Quotient Sciences
TRIAL MONITORING
The Latest On RBM Uptake? Tufts Says Most, But Not All, Pharma On Board
A conversation with Beth Harper, Tufts CSDD
SCOPE 2026 In The Rear-View Mirror
By Darcy Grabenstein, Citeline
CLINICAL DATA MANAGEMENT & ANALYTICS
How Deep Learning Is Changing Clinical Trial Design, Execution, And Analysis In 2026
By Partha Anbil
5 Ways An AI-Designed Study Can Close The Speed-To-Therapy Gap
Medidata, a Dassault Systemes company
The Strategic Role Of Biostatistics In Clinical Trials
Ergomed Clinical Research
Revolutionizing Clinical Analytics
Revvity Signals Software, Inc.
